Fig. 1.

Post hoc analysis (one-way ANOVA) for mean change in outcome variables between different groups
| Variables | SMWLM | HVLA | NM | CT | F | p |
|---|---|---|---|---|---|---|
| Mean VAS change | 6.05 ± 1.32 | 3.68 ± 0.75 | 3.2 ± 0.62 | 1.91 ± 1.22 | 57.94 | 0.0001* |
| Mean ODI change | 15.65 ± 2.43 | 11.89 ± 1.29 | 10.85 ± 1.53 | 3.77 ± 2.43 | 126.62 | 0.0001* |
| Mean SLR ROM change | 15.06 ± 3.1 | 7.89 ± 2.21 | 7.07 ± 2.58 | 1.59 ± 2.58 | 89.66 | 0.0001* |
One-way ANOVA for baseline characteristics
| SMWLM | HVLA | NM | CT | F | p | |
|---|---|---|---|---|---|---|
| VAS | 8.1 ± 0.97 | 8 ± 0.88 | 7.8 ± 1.15 | 8.1 ± 0.77 | 0.438 | 0.726 |
| ODI | 26.75 ± 2.4 | 27.84 ± 1.68 | 27.6 ± 1.6 | 27.76 ± 1.18 | 1.615 | 0.193 |
| SLR ROM | 48.44 ± 1.17 | 47.87 ± 1.16 | 48.72 ± 1.53 | 48.56 ± 1 | 1.719 | 0.17 |
Repeated measures for VAS, ODI and SLR ROM scores of all groups at different levels of protocol
| Groups | Pre-intervention | Post-intervention | Follow-up | F | p | |
|---|---|---|---|---|---|---|
| Mean ± SD | ||||||
| SMWLM | VAS | 8.1 ± 0.97 | 2.05 ± 1.05 | 1.8 ± 1.32 | 305.742 | 0.0001* |
| ODI | 26.75 ± 2.4 | 11.1 ± 0.85 | 11.15 ± 1.14 | 778.633 | 0.0001* | |
| SLR ROM | 48.44 ± 1.17 | 63.5 ± 3.67 | 63.72 ± 4.68 | 333.034 | 0.0001* | |
| HVLA | VAS | 8 ± 0.88 | 4.32 ± 1.34 | 4.32 ± 1.7 | 242.975 | 0.0001* |
| ODI | 27.84 ± 1.68 | 15.95 ± 0.91 | 16.05 ± 1.35 | 1283.527 | 0.0001* | |
| SLR ROM | 47.87 ± 1.16 | 55.76 ± 2.47 | 55.72 ± 2.5 | 230.264 | 0.0001* | |
| NM | VAS | 7.8 ± 1.15 | 4.6 ± 0.94 | 4.65 ± 0.88 | 208.793 | 0.0001* |
| ODI | 27.6 ± 1.6 | 16.75 ± 2.05 | 16.6 ± 2.06 | 816.590 | 0.0001* | |
| SLR ROM | 48.71 ± 1.53 | 55.79 ± 2.18 | 55.68 ± 2.12 | 153.051 | 0.0001* | |
| CT | VAS | 8.1 ± 0.77 | 6.19 ± 1.08 | 6.29 ± 1.15 | 38.779 | 0.0001* |
| ODI | 27.76 ± 1.18 | 24 ± 1.95 | 24.19 ± 1.69 | 53.330 | 0.0001* | |
| SLR ROM | 48.56 ± 1 | 50.14 ± 2.57 | 50.17 ± 2.8 | 7.013 | 0.0002* | |